Atea Pharmaceuticals jumps on $5.75 a share takeover offer from Tang Capital
278.13MUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US04683R1068
CUSIP
04683R106
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
4.80
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.65
Wall Street Target Price
7.50
EPS Estimate Current Year
-2.02
EPS Estimate Next Year
-1.64
EPS Estimate Current Quarter
-0.4107
EPS Estimate Next Quarter
-0.4144
Most Recent Quarter
-
Revenue TTM
192,180,000
Gross Profit TTM
-80,826,000
EBITDA
-101,035,000
Profit Margin
0.00%
Return On Assets TTM
-12.77%
Return On Equity TTM
-30.47%
Revenue Per Share TTM
2.31
Qtly Revenue Growth YOY
295.20%
Diluted Eps TTM
-1.65
Qtly Earnings Growth YOY
264.10%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
1.9026
Price Book MRQ
0.6766
Enterprise Value Revenue
58
Enterprise Value EBITDA
-260
257.51
4.39%90.45
1.63%188.94
1.42%313.25
1.13%445.00
0.94%512.58
0.66%586.54
0.00%148.56
0.00%77.85
-1.44%540.76
-0.27%